Cargando…

95% effective volume of ropivacaine for ultrasound‑guided supra‑inguinal fascia iliaca compartment block

BACKGROUND: Hip arthroplasty is effective in treating hip diseases, such as osteoarthritis and hip fracture, but it often brings severe trauma and pain. In recent years, ultrasound-guided supra-inguinal fascia iliaca compartment block(S-FICB) has become a widely used nerve block method for analgesia...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Can, Dai, Wei, He, Kaihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053470/
https://www.ncbi.nlm.nih.gov/pubmed/36991333
http://dx.doi.org/10.1186/s12871-023-02049-5
_version_ 1785015421516120064
author Zhang, Can
Dai, Wei
He, Kaihua
author_facet Zhang, Can
Dai, Wei
He, Kaihua
author_sort Zhang, Can
collection PubMed
description BACKGROUND: Hip arthroplasty is effective in treating hip diseases, such as osteoarthritis and hip fracture, but it often brings severe trauma and pain. In recent years, ultrasound-guided supra-inguinal fascia iliaca compartment block(S-FICB) has become a widely used nerve block method for analgesia in hip arthroplasty. METHODS: Fifty-three patients preparing for hip arthroplasty were prospectively enrolled. S-FICB was performed under ultrasound guidance, and inject 0.33% ropivacaine into the space. Using the biased-coin design (BCD) sequential allocation method. The initial volume of 0.33% ropivacaine was 30ml. In case of failure, the next patient received a higher volume (defined as the previous volume with an increment of 1.2 mL). If the previous patient had a successful block, the next patient was randomized to a lower volume (defined as the previous volume with a decrement of 1.2 mL), with a probability of b = 0.05, or the same volume, with a probability of 1 − b = 0.95. The study was stopped when 45 successful blocks were achieved. RESULTS: Forty-five patients (84.9%) were blocked successfully. The 95% effective volume (EV95) was 34.06ml (95%CI 33.35 ~ 36.28ml). There were 31 patients with non-fracture in this study. The quadriceps muscle strength decreased in only two patients. Moreover, they both received 34.8ml of ropivacaine for S-FICB. Twenty-two patients had hip fractures. There were 3 patients (14%) with failed blocks and 19 patients (86%) with successful blocks. However, all fracture patients experienced less pain after S-FICB. CONCLUSION: EV95 of 0.33% ropivacaine for ultrasound-guided S-FICB was 34.06ml. TRIAL REGISTRATION: The trial was registered at the Chinese Clinical Trial Registry (registration number: ChiCTR2100052214, registration date: 2021 October 22).
format Online
Article
Text
id pubmed-10053470
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100534702023-03-30 95% effective volume of ropivacaine for ultrasound‑guided supra‑inguinal fascia iliaca compartment block Zhang, Can Dai, Wei He, Kaihua BMC Anesthesiol Research BACKGROUND: Hip arthroplasty is effective in treating hip diseases, such as osteoarthritis and hip fracture, but it often brings severe trauma and pain. In recent years, ultrasound-guided supra-inguinal fascia iliaca compartment block(S-FICB) has become a widely used nerve block method for analgesia in hip arthroplasty. METHODS: Fifty-three patients preparing for hip arthroplasty were prospectively enrolled. S-FICB was performed under ultrasound guidance, and inject 0.33% ropivacaine into the space. Using the biased-coin design (BCD) sequential allocation method. The initial volume of 0.33% ropivacaine was 30ml. In case of failure, the next patient received a higher volume (defined as the previous volume with an increment of 1.2 mL). If the previous patient had a successful block, the next patient was randomized to a lower volume (defined as the previous volume with a decrement of 1.2 mL), with a probability of b = 0.05, or the same volume, with a probability of 1 − b = 0.95. The study was stopped when 45 successful blocks were achieved. RESULTS: Forty-five patients (84.9%) were blocked successfully. The 95% effective volume (EV95) was 34.06ml (95%CI 33.35 ~ 36.28ml). There were 31 patients with non-fracture in this study. The quadriceps muscle strength decreased in only two patients. Moreover, they both received 34.8ml of ropivacaine for S-FICB. Twenty-two patients had hip fractures. There were 3 patients (14%) with failed blocks and 19 patients (86%) with successful blocks. However, all fracture patients experienced less pain after S-FICB. CONCLUSION: EV95 of 0.33% ropivacaine for ultrasound-guided S-FICB was 34.06ml. TRIAL REGISTRATION: The trial was registered at the Chinese Clinical Trial Registry (registration number: ChiCTR2100052214, registration date: 2021 October 22). BioMed Central 2023-03-29 /pmc/articles/PMC10053470/ /pubmed/36991333 http://dx.doi.org/10.1186/s12871-023-02049-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Can
Dai, Wei
He, Kaihua
95% effective volume of ropivacaine for ultrasound‑guided supra‑inguinal fascia iliaca compartment block
title 95% effective volume of ropivacaine for ultrasound‑guided supra‑inguinal fascia iliaca compartment block
title_full 95% effective volume of ropivacaine for ultrasound‑guided supra‑inguinal fascia iliaca compartment block
title_fullStr 95% effective volume of ropivacaine for ultrasound‑guided supra‑inguinal fascia iliaca compartment block
title_full_unstemmed 95% effective volume of ropivacaine for ultrasound‑guided supra‑inguinal fascia iliaca compartment block
title_short 95% effective volume of ropivacaine for ultrasound‑guided supra‑inguinal fascia iliaca compartment block
title_sort 95% effective volume of ropivacaine for ultrasound‑guided supra‑inguinal fascia iliaca compartment block
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053470/
https://www.ncbi.nlm.nih.gov/pubmed/36991333
http://dx.doi.org/10.1186/s12871-023-02049-5
work_keys_str_mv AT zhangcan 95effectivevolumeofropivacaineforultrasoundguidedsuprainguinalfasciailiacacompartmentblock
AT daiwei 95effectivevolumeofropivacaineforultrasoundguidedsuprainguinalfasciailiacacompartmentblock
AT hekaihua 95effectivevolumeofropivacaineforultrasoundguidedsuprainguinalfasciailiacacompartmentblock